Advertisement

Calabria: a successful experience implementing Herpes Zoster vaccination strategies

  • Sandro GiuffridaEmail author
Short Communication
  • 10 Downloads

Abstract

Recently, the National Immunization Plan (NIP) in Italy has highlighted the importance of immunization practices also for adults, including vaccinations against influenza, Pneumococcus (PNO) and HZ. In response to the NIP, the Calabria region decided to offer HZ vaccination to the two cohorts of 65- and 70-year-old subjects. We at the Reggio Calabria Local Health Services, concentrated our efforts on addressing all the above-mentioned shortcomings and, as a first measure, we addressed the convenience problem by scheduling the HZ vaccine administration during the same visit as the pneumococcal vaccination (PCV13 vaccine). The adhesion rates were satisfactory in both cohorts—such high levels of vaccine coverage for HZ and PCV13 had never been reached before in our region and are still among the highest in Italy. However, the main result was undoubtedly the significantly high rate of PCV13 and HZ vaccine co-administration without safety problems.

Keywords

Herpers zoster vaccine Co-administration PCV13 vaccine 

Notes

Compliance with ethical standards

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Statement of human and animal rights

All procedures performed in this study were in accordance with the ethical standards of the institutional research committee (Ethical approval by the Ethical Committee of the Department of Medicine, Helsinki University Central Hospital) and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Miller E, Marshall R, Vurdien J (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4:222–230CrossRefGoogle Scholar
  2. 2.
    Kawai K, Gebremeskel BG, Acosta CJ (2014) Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4:e004833CrossRefGoogle Scholar
  3. 3.
    Alicino C, Trucchi C, Paganino C et al (2017) Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study. Hum Vaccines Immunother 13:399–404CrossRefGoogle Scholar
  4. 4.
    Bricout H, Perinetti E, Marchettini P et al (2014) Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009–2010): a GP-based prospective cohort study. BMC Infect Dis 14:63CrossRefGoogle Scholar
  5. 5.
    Oxman MN, Levin MJ, Johnson GR et al (2005) A vaccine to prevent Herpes Zoster and Post-Herpetic Neuralgias in older adults. N Engl J Med 352:2271–2284CrossRefGoogle Scholar
  6. 6.
    Schmader KE, Levin MJ, Gnann JW et al (2012) Efficacy, safety and tolerability of Herpes Zoster vaccine in persons aged 50–59 years. Clin Infect Dis 54:922–928CrossRefGoogle Scholar
  7. 7.
    Schmader KE, Oxman MN, Levin MJ et al (2012) Persistence of the efficacy of zoster vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy. Clin Infect Dis 55:1320–1328.  https://doi.org/10.1093/cid/cis638 CrossRefGoogle Scholar
  8. 8.
    Morrison VA, Johnson GR, Schmader KE et al (2015) Long-term persistence of zoster vaccine efficacy. Clin Infect Dis 60:900–909.  https://doi.org/10.1093/cid/ciu918 CrossRefGoogle Scholar
  9. 9.
    Aspinall R, Del Giudice G, Effros RB et al (2007) Challenges for vaccination in the elderly. Immun Ageing 4:9CrossRefGoogle Scholar
  10. 10.
    Baxter R, Bartlett J, Fireman B et al (2017) Long-term effectiveness of the live zoster vaccine in preventing shingles: a Cohort study. Am J Epidemiol 187(1):161–169.  https://doi.org/10.1093/aje/kwx245 CrossRefGoogle Scholar
  11. 11.
    Amirthalingam G, Andrews N, Kell P et al (2017) Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study. Lancet Public Health 2018 3:e82–e90CrossRefGoogle Scholar
  12. 12.
    Gagliardi AMZ, Andriolo BNG, Torloni MR et al (2016) Vaccines for preventing herpes zoster in older adults. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.CD008858.pub3 Google Scholar
  13. 13.
  14. 14.
  15. 15.
    MacIntyre R, Menzies R, Kpozehoueet E al (2016) Equity in disease prevention: vaccines for the older adults—a national workshop. Vaccine 34:5463–5469CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Azienda Sanitaria Provinciale di Reggio CalabriaReggioItaly

Personalised recommendations